MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Inventory
Credit loss expense
Depreciation and amortization
Others
Negative Cash Flow Breakdown
Net (loss) income
Cash paid for share repurchases ...
Accounts payable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net (loss) income
-14,840
-10,860
15,191
16,748
Depreciation and amortization
1,531
-10,044
-
5,290
Credit loss expense
5,281
1,464
3,366
2,056
Non-cash lease expenses
334
330
325
318
Share-based compensation
903
-1,696
2,463
4,919
Shares received in settlement of litigation
-
-
0
0
Depreciation and amortization
-
-
14,881
-
Loss on extinguishment of debt
-
-
0
0
Deferred income taxes
3,168
4,531
-2,051
-5,751
Other
104
118
98
249
Accounts receivable
545
-28,209
887
11,014
Inventory
-5,298
889
-1,162
1,612
Prepaid expenses
-
-
-
-615
Other assets
-1,270
-2,012
3,117
3,440
Accounts payable
-3,170
1,936
-1,586
2,913
Accrued compensation
-1,349
-15,706
3,415
6,362
Accrued expenses
218
-375
-1,441
284
Other liabilities
-1,882
250
1,466
-110
Net cash flows from operating activities of continuing operations
-
-
24,956
29,329
Net cash flows used in operating activities of discontinued operations
-
-
0
0
Net cash flows (used in) provided by operating activities
-10,015
1,879
24,956
29,329
Cash paid for acquisitions
0
5,000
0
3,064
Purchases of equipment
598
570
285
192
Repayment of previous term loan
-
-
0
0
Patent application costs
37
33
-
2
Repayment of citizens revolving credit facility
-
-
0
0
Other investments
-
-
89
2,000
Proceeds from exercise of stock options
-
-
0
0
Net cash flows used in investing activities
-635
-5,642
-335
-5,258
Cash paid for share repurchases pursuant to share repurchase plan
12,468
-
0
-
Stock repurchased for tax withholdings on vesting of restricted stock
127
1,901
51
83
Principal payments on citizens term loan facility
-375
-375
1,750
-250
Cash paid for profit share payment (note 12)
298
309
282
524
Proceeds from citizens revolving credit facility
-
-
0
0
Proceeds from citizens term loan
-
-
0
0
Prepayment premium on previous term loan
-
-
0
0
Principal payments on finance lease
-
-
-
0
Other
-
-
0
-
Deferred financing cost
16
-
0
0
Net cash flows used in financing activities
-13,284
-2,585
-583
-857
Net change in cash
-23,934
-6,348
24,038
23,214
Cash and cash equivalents, beginning of period
159,773
166,121
142,083
104,416
Cash and cash equivalents, end of period
135,839
159,773
166,121
142,083
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net change in cash
-$23,934K
(-265.60%↓ Y/Y)
Inventory
-$5,298K
(-589.20%↓ Y/Y)
Credit loss expense
$5,281K
(383.17%↑ Y/Y)
Depreciation and
amortization
$1,531K
(-75.97%↓ Y/Y)
Other assets
-$1,270K
(-156.17%↓ Y/Y)
Share-based compensation
$903K
(-89.98%↓ Y/Y)
Non-cash lease expenses
$334K
(-46.04%↓ Y/Y)
Accrued expenses
$218K
(-93.82%↓ Y/Y)
Other
$104K
(-64.63%↓ Y/Y)
Net cash flows used
in financing...
-$13,284K
(-234.44%↓ Y/Y)
Net cash flows (used
in) provided by...
-$10,015K
(-150.79%↓ Y/Y)
Net cash flows used
in investing...
-$635K
(50.89%↑ Y/Y)
Canceled cashflow
$14,939K
Cash paid for share
repurchases pursuant to...
$12,468K
Principal payments on
citizens term loan...
-$375K
(25.00%↑ Y/Y)
Cash paid for profit
share payment (note...
$298K
(-38.93%↓ Y/Y)
Stock repurchased for
tax withholdings on...
$127K
(-95.74%↓ Y/Y)
Deferred financing cost
$16K
Net (loss) income
-$14,840K
(-189.19%↓ Y/Y)
Purchases of equipment
$598K
(7.55%↑ Y/Y)
Patent application
costs
$37K
(0.00%↑ Y/Y)
Accounts payable
-$3,170K
(-500.25%↓ Y/Y)
Deferred income taxes
$3,168K
(448.90%↑ Y/Y)
Other liabilities
-$1,882K
(-76.38%↓ Y/Y)
Accrued compensation
-$1,349K
(-70.54%↓ Y/Y)
Accounts receivable
$545K
(-96.24%↓ Y/Y)
Buy us a coffee
MIMEDX GROUP, INC. (MDXG)
MIMEDX GROUP, INC. (MDXG)